Brachytherapy
Overview
Affiliations
Brachytherapy is the preferred radiation treatment modality for various intraocular tumors, most commonly, uveal melanoma. Radioactive sources are placed directly onto or around the tumor with the aid of episcleral plaques, whereby the employed sources exhibit an extremely sharp fall-off of dosage outside the few millimeters around the tumor. With such high focality, radiation dose to vision critical structures is minimized. Various sources have been used over the years, with iodine-125 being the most common. This chapter will highlight the history of brachytherapy for the treatment of intraocular tumors, current practice including isotopes and plaques utilized, as well as a comprehensive treatment planning and physics review.
Du J, Ren W, Liu W, Zhou Y, Li Y, Lai Q BMC Cancer. 2025; 25(1):245.
PMID: 39939898 PMC: 11818262. DOI: 10.1186/s12885-025-13666-3.
Soroko S, Skamnitskiy D, Gorshkova E, Kutova O, Seriev I, Maslennikova A Curr Issues Mol Biol. 2024; 46(12):13860-13880.
PMID: 39727956 PMC: 11726848. DOI: 10.3390/cimb46120828.
Manganese-based nanomaterials in diagnostics and chemodynamic therapy of cancers: new development.
Wu M, Liao Y, Guo D, Zhai M, Xia D, Zhang Z RSC Adv. 2024; 14(21):14722-14741.
PMID: 38716093 PMC: 11074770. DOI: 10.1039/d4ra01655f.
Yang L, Wang C, Zhang W, Liu S, Xuan T, Jiang H Front Oncol. 2023; 12:1005876.
PMID: 36591479 PMC: 9797954. DOI: 10.3389/fonc.2022.1005876.
Ortiz-Seller A, Martinez-Costa R, Calatayud J, Palacios I, Hernandez A, Barranco Gonzalez H J Contemp Brachytherapy. 2022; 14(3):273-277.
PMID: 36199993 PMC: 9528837. DOI: 10.5114/jcb.2022.116926.